Megerso Abebe, Garoma Sileshi
Adama Hospital Medical College, P.O. Box 3092, Adama, Ethiopia.
BMC Health Serv Res. 2016 Oct 18;16(1):581. doi: 10.1186/s12913-016-1818-3.
Antiretroviral treatment (ART) service scaling up has been practiced in the Ethiopia since 2006. Regardless of increasing number of primary health care centers providing the service, the existing hospitals are still overcrowded with ART service seeking patients may be because of the common belief that treatment outcome is better for hospital patients than those treated at the primary health centers. However, documented evidence comparing the treatment outcome for the two categories of health facilities is scarce in the study setting. The purpose of the current study was to compare major treatment outcomes among new patients treated at the two health facility categories.
Retrospective cohort study was implemented using secondary data from medical records collected between October 2010 and January 2014 in the selected health facilities. All patients (1895) who started the treatment in the facilities during the period were included in the study. Univariate analyses were made using descriptive methods such as frequency distributions and measures of central tendency. Bivariate and multivariate analyses were made using Kaplan Meier and Cox regression models respectively to compare the mean survival time between the two facility categories. P-value less than 0.05 was considered as statistically significant.
A total of 1895 patient records were followed for 27,990 person-months. Risks of unwanted treatment outcomes (death and lose-to-follow-up) were the same for both categories of patients. The median survival probability was similar to the facility categories (P-value = 0.11). Baseline performance scale III/IV (AHR, 2.4; 95 % CI: 2.0, 3.0), baseline WHO clinical stages III/IV (AHR, 2.8; 95 % CI: 2.3, 3.4), and low adherence (<95 %) to ART drugs (AHR, 3.4; 95 % CI: 2.8, 5.2) were the independent predictors of the unwanted treatment outcomes.
Antiretroviral treatment service delivery at primary health care facilities did not compromise the treatment outcomes among adult ART naïve patients. This implies that, ART services decentralization can result in acceptable treatment outcome in less developed settings. Therefore, treatment requiring patients should be encouraged to start the treatment in either of the health facilities as early as possible.
自2006年以来,埃塞俄比亚一直在扩大抗逆转录病毒治疗(ART)服务。尽管提供该服务的初级卫生保健中心数量不断增加,但现有医院中寻求抗逆转录病毒治疗服务的患者仍然人满为患,这可能是因为人们普遍认为医院患者的治疗效果优于在初级卫生保健中心接受治疗的患者。然而,在该研究环境中,比较这两类卫生机构治疗效果的文献证据很少。本研究的目的是比较在这两类卫生机构接受治疗的新患者的主要治疗效果。
采用回顾性队列研究,使用2010年10月至2014年1月在选定卫生机构收集的病历中的二手数据。在此期间在这些机构开始治疗的所有患者(1895例)均纳入研究。使用频率分布和集中趋势度量等描述性方法进行单变量分析。分别使用Kaplan Meier模型和Cox回归模型进行双变量和多变量分析,以比较这两类机构之间的平均生存时间。P值小于0.05被认为具有统计学意义。
共对1895份患者记录进行了27990人月的随访。两类患者出现不良治疗结局(死亡和失访)的风险相同。中位生存概率在两类机构中相似(P值 = 0.11)。基线表现量表III/IV(风险比[AHR],2.4;95%置信区间[CI]:2.0,3.0)、基线世界卫生组织临床分期III/IV(AHR,2.8;95%CI:2.3,3.4)以及对抗逆转录病毒药物的低依从性(<95%)(AHR,3.4;95%CI:2.8,5.2)是不良治疗结局的独立预测因素。
初级卫生保健机构提供的抗逆转录病毒治疗服务不会损害初治成年抗逆转录病毒治疗患者的治疗效果。这意味着,在欠发达地区,抗逆转录病毒治疗服务的分散化可带来可接受的治疗效果。因此,应鼓励有治疗需求的患者尽早在任何一类卫生机构开始治疗。